Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non–Small-cell Lung Cancer

Bibliographic Details
Title: Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non–Small-cell Lung Cancer
Authors: Bordoni, Rodolfo, Ciardiello, Fortunato, von Pawel, Joachim, Cortinovis, Diego, Karagiannis, Thomas, Ballinger, Marcus, Sandler, Alan, Yu, Wei, He, Pei, Matheny, Christina, Felizzi, Federico, Rittmeyer, Achim
Source: In Clinical Lung Cancer September 2018 19(5):441-449
Database: ScienceDirect
More Details
ISSN:15257304
DOI:10.1016/j.cllc.2018.05.011
Published in:Clinical Lung Cancer
Language:English